CRISPR Therapeutics AG (CRSP) EBT Margin (2016 - 2026)
CRISPR Therapeutics AG's EBT Margin came in at -879.02% for Q3 2026, up 11024.47 percentage points from -11903.49% a year earlier and up 6.89 percentage points from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) EBT Margin (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, CRISPR Therapeutics AG reported EBT Margin of -1802.19%, down 538.20 percentage points year-over-year; for FY2025, it was -16466.24%, down 15494.31 percentage points from FY2024.
- EBT Margin carries a five-year change of +31942.11 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -971.93% in FY2024 (-931.32 pp), -40.60% in FY2023 (+54258.23 pp), -54298.83% in FY2022 (-54340.31 pp) and 41.48% in FY2021 (+48449.83 pp).
- The Q3 2026 figure represents the highest quarterly EBT Margin since Q4 2024.
- Year-over-year, EBT Margin has increased for three consecutive quarters, with an average year-over-year change of +4511.48 percentage points over the last eight quarters.
- The fastest year-over-year change in EBT Margin over five years came in Q4 2023 (a gain of 2000894.52 percentage points), and the weakest in Q4 2022 (a drop of 1999737.50 percentage points).
- Business Quant data shows CRSP's EBT Margin at -885.91% (Q2 2026), -8373.94% (Q1 2026) and -15046.18% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | CRISPR Therapeutics AG | 4.65 Bn | -4.41 Bn | - | -879.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -879.02% |
| Jun 30, 2026 | -885.91% |
| Mar 31, 2026 | -8,373.94% |
| Dec 31, 2025 | -15,046.18% |
| Sep 30, 2025 | -11,903.49% |
| Jun 30, 2025 | -23,235.09% |
| Mar 31, 2025 | -15,593.87% |
| Dec 31, 2024 | -102.58% |
| Sep 30, 2024 | -14,130.56% |
| Jun 30, 2024 | -24,201.35% |
| Mar 31, 2024 | -22,989.48% |
| Dec 31, 2023 | 44.52% |
| Jun 30, 2023 | -109.74% |
| Mar 31, 2023 | -51.75% |
| Dec 31, 2022 | -2,000,850.00% |
| Sep 30, 2022 | -186,302.13% |
| Jun 30, 2022 | -113,744.30% |
| Mar 31, 2022 | -18,681.81% |
| Dec 31, 2021 | -1,112.50% |
| Sep 30, 2021 | -15,503.40% |
API Access
CRISPR Therapeutics AG EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();